rs1805078

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBA1

The NM_000153.4(GALC):​c.550C>T​(p.Arg184Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0511 in 1,612,988 control chromosomes in the GnomAD database, including 2,422 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign,other (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R184H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.039 ( 175 hom., cov: 32)
Exomes 𝑓: 0.052 ( 2247 hom. )

Consequence

GALC
NM_000153.4 missense

Scores

2
7
9

Clinical Significance

Benign; other criteria provided, multiple submitters, no conflicts B:8O:2

Conservation

PhyloP100: 2.62

Publications

40 publications found
Variant links:
Genes affected
GALC (HGNC:4115): (galactosylceramidase) This gene encodes a lysosomal protein which hydrolyzes the galactose ester bonds of galactosylceramide, galactosylsphingosine, lactosylceramide, and monogalactosyldiglyceride. Mutations in this gene have been associated with Krabbe disease, also known as globoid cell leukodystrophy. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]
GALC Gene-Disease associations (from GenCC):
  • Krabbe disease
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Myriad Women’s Health, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), PanelApp Australia, ClinGen, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 94 curated pathogenic missense variants (we use a threshold of 10). The gene has 16 curated benign missense variants. Gene score misZ: 0.18582 (below the threshold of 3.09). Trascript score misZ: -0.28853 (below the threshold of 3.09). GenCC associations: The gene is linked to Krabbe disease.
BP4
Computational evidence support a benign effect (MetaRNN=0.0072863996).
BP6
Variant 14-87984426-G-A is Benign according to our data. Variant chr14-87984426-G-A is described in ClinVar as Benign|other. ClinVar VariationId is 92506.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.055 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GALCNM_000153.4 linkc.550C>T p.Arg184Cys missense_variant Exon 5 of 17 ENST00000261304.7 NP_000144.2 P54803-1A0A0A0MQV0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GALCENST00000261304.7 linkc.550C>T p.Arg184Cys missense_variant Exon 5 of 17 1 NM_000153.4 ENSP00000261304.2 P54803-1

Frequencies

GnomAD3 genomes
AF:
0.0388
AC:
5900
AN:
151994
Hom.:
175
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0111
Gnomad AMI
AF:
0.0495
Gnomad AMR
AF:
0.0317
Gnomad ASJ
AF:
0.0135
Gnomad EAS
AF:
0.00578
Gnomad SAS
AF:
0.0346
Gnomad FIN
AF:
0.0706
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.0565
Gnomad OTH
AF:
0.0355
GnomAD2 exomes
AF:
0.0417
AC:
10401
AN:
249442
AF XY:
0.0428
show subpopulations
Gnomad AFR exome
AF:
0.00982
Gnomad AMR exome
AF:
0.0203
Gnomad ASJ exome
AF:
0.0139
Gnomad EAS exome
AF:
0.00200
Gnomad FIN exome
AF:
0.0693
Gnomad NFE exome
AF:
0.0570
Gnomad OTH exome
AF:
0.0423
GnomAD4 exome
AF:
0.0523
AC:
76449
AN:
1460876
Hom.:
2247
Cov.:
31
AF XY:
0.0520
AC XY:
37819
AN XY:
726784
show subpopulations
African (AFR)
AF:
0.00786
AC:
263
AN:
33478
American (AMR)
AF:
0.0213
AC:
953
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.0136
AC:
356
AN:
26132
East Asian (EAS)
AF:
0.0112
AC:
446
AN:
39688
South Asian (SAS)
AF:
0.0366
AC:
3153
AN:
86240
European-Finnish (FIN)
AF:
0.0689
AC:
3679
AN:
53402
Middle Eastern (MID)
AF:
0.0257
AC:
148
AN:
5768
European-Non Finnish (NFE)
AF:
0.0582
AC:
64626
AN:
1111082
Other (OTH)
AF:
0.0468
AC:
2825
AN:
60366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.454
Heterozygous variant carriers
0
3285
6569
9854
13138
16423
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2326
4652
6978
9304
11630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0388
AC:
5896
AN:
152112
Hom.:
175
Cov.:
32
AF XY:
0.0379
AC XY:
2819
AN XY:
74348
show subpopulations
African (AFR)
AF:
0.0111
AC:
459
AN:
41504
American (AMR)
AF:
0.0315
AC:
481
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.0135
AC:
47
AN:
3470
East Asian (EAS)
AF:
0.00579
AC:
30
AN:
5178
South Asian (SAS)
AF:
0.0347
AC:
167
AN:
4816
European-Finnish (FIN)
AF:
0.0706
AC:
746
AN:
10568
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.0565
AC:
3840
AN:
67988
Other (OTH)
AF:
0.0346
AC:
73
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
280
561
841
1122
1402
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
72
144
216
288
360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0483
Hom.:
780
Bravo
AF:
0.0336
TwinsUK
AF:
0.0591
AC:
219
ALSPAC
AF:
0.0618
AC:
238
ESP6500AA
AF:
0.0114
AC:
44
ESP6500EA
AF:
0.0561
AC:
463
ExAC
AF:
0.0431
AC:
5212
Asia WGS
AF:
0.0210
AC:
74
AN:
3478
EpiCase
AF:
0.0526
EpiControl
AF:
0.0498

ClinVar

Significance: Benign; other
Submissions summary: Benign:8Other:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Oct 27, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Galactosylceramide beta-galactosidase deficiency Benign:2Other:2
-
GeneReviews
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jan 06, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:other
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- pseudodeficiency allele

not provided Benign:2
Jan 04, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 32661301, 26865610, 26795590, 7581365, 21228398, 20981092, 22995991) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.092
BayesDel_addAF
Benign
-0.25
T
BayesDel_noAF
Benign
-0.090
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.85
D;.;.;.
Eigen
Benign
0.11
Eigen_PC
Benign
0.078
FATHMM_MKL
Uncertain
0.83
D
LIST_S2
Pathogenic
0.98
D;D;D;D
MetaRNN
Benign
0.0073
T;T;T;T
MetaSVM
Uncertain
0.24
D
MutationAssessor
Benign
1.5
L;.;.;.
PhyloP100
2.6
PrimateAI
Benign
0.24
T
PROVEAN
Uncertain
-3.8
D;D;D;D
REVEL
Uncertain
0.49
Sift
Uncertain
0.027
D;D;D;D
Sift4G
Uncertain
0.0080
D;D;D;D
Polyphen
0.99
D;P;D;.
Vest4
0.14
MPC
0.43
ClinPred
0.029
T
GERP RS
1.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.13
gMVP
0.68
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1805078; hg19: chr14-88450770; API